RYR2 and Arrhythmia: Although these data indicate that HIV-Tat, ATV, EFV, and RTV can modulate RyR2 in cardiac myocytes, additional studies in clinically relevant models must be conducted to determine if these drugs are capable of triggering arrhythmias and even SCD.